Earth Science Tech, Inc.
Earth Science Tech, Inc. is a U.S.-based healthcare and wellness company operating through subsidiaries including Peaks, DOC, Villas, RxCompoundstore, Avenvi, and Mister Meds. Its business spans telehealth, pharmacy/compounding, and related wellness offerings, with revenue driven by customer acquisition, brand building, and the ability to keep patients engaged across a fast-changing digital health market.
Fiscal year 2026 · change from previous year
Development 2021–2026
Business
Share of revenueVirtual healthcare offerings delivered through the company's telehealth brands and provider network.
Prescription fulfillment and compounded medication services handled through pharmacy operations.
Consumer-facing wellness and condition-focused offerings marketed through the platform.
Digital marketing, influencer, and brand-led demand generation that supports customer growth.
Products
Reported · share of revenue- Sale of Pharmaceutical Products and Medical Consultations92.2 %
- Shipping and Handling7.0 %
- Other Revenue0.8 %
Source: 10-K FY2026, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
The company serves consumers seeking telehealth, pharmacy, and wellness solutions, with demand driven by convenience, access, and brand trust. Its customer base also includes patients using condition-specific services offered through affiliated healthcare providers and pharmacy channels. Growth depends on attracting new users, retaining existing customers, and maintaining market acceptance in a competitive digital health environment.
Patients using Peaks, DOC, and Villas for virtual consultations and ongoing care.
Customers filling prescriptions or compounded medications through RxCompound and Mister Meds.
Consumers buying wellness-related offerings marketed through the company's brands and social channels.
Patients seeking treatment for specific conditions available through the platform's provider network.
Strategy
Management is focused on expanding the scope of offerings, growing the number and quality of healthcare providers, and increasing the conditions that can be treated through the platform. The company also emphasizes brand building, digital marketing, and customer retention because its model depends on awareness, trust, and repeat engagement. Operational resilience at its pharmacy and fulfillment sites is also strategically important because service continuity supports customer experience and growth.
More products, services, and treatable conditions can increase customer lifetime value and market reach.
Revenue depends on marketing effectiveness, platform engagement, and repeat usage.
Centralized inventory and affiliated-provider operations create service and reputational risk if disrupted.
Geography
The company is headquartered in the United States and its disclosed operations are centered there. The reports specifically mention inventory housed in Miami, Florida and Abilene, Texas, which makes U.S. logistics and facility continuity important to service levels. No country-level revenue split was disclosed in the provided excerpts.
Risks
The business is exposed to customer acquisition risk, regulatory risk, and brand/reputation risk because its model relies on digital marketing, healthcare compliance, and consumer trust. It also faces execution risk from centralized inventory locations, affiliated-provider conduct, and competition from larger healthcare and pharmacy players. As a smaller reporting company in a rapidly evolving market, quarterly volatility and acquisition/integration risk are also meaningful.
- Customer acquisition and retention failureImpact: HighLikelihood: Medium
The company says growth depends on marketing and platform engagement; weak demand generation would hurt revenue.
Exposure: Telehealth and wellness customer funnel
- Healthcare, privacy, and advertising regulationImpact: HighLikelihood: Medium
Changes in laws can restrict outreach, increase compliance costs, or trigger penalties.
Exposure - Brand and reputational damageImpact: HighLikelihood: Medium
The company relies heavily on brand strength and social/influencer marketing, which can backfire if misused.
Exposure: Consumer-facing healthcare brands
- Centralized inventory disruptionImpact: HighLikelihood: Medium
Inventory is housed at two facilities; damage or interruption could impair order fulfillment.
Exposure - Competition from larger healthcare and pharmacy companiesImpact: MediumLikelihood: Medium
Better-capitalized rivals may outspend the company on marketing, technology, and provider networks.
Exposure
Accounting
Judgemental itemsProduct sales are recognized at point of sale or shipment, which affects timing of reported revenue.
Impact: Can shift revenue between periods depending on fulfillment terms
Acquired businesses and reporting units must be tested for impairment, especially in a volatile market.
Impact: Potential non-cash charges to earnings
Changes in market value are recognized in earnings under ASC 321.
Impact: Can create volatility in net income
Management cites judgment in taxation, asset lives, contingencies, and going concern assessment.
Impact: Affects reserves, depreciation/amortization, and reported risk profile
Similar listed companies
Publicly listed companies with a comparable business focus.
BioScience Health Innovations, Inc.
BHIC · Services-Computer Processing & Data Preparation
Eco Science Solutions, Inc.
ESSI · Retail-Miscellaneous Retail
Global Technologies LTD
GTLL · Radio & Tv Broadcasting & Communications Equipment
Mannatech, Incorporated
MTEX · Medicinal Chemicals & Botanical Products
Scienture Holdings, Inc.
SCNX · Pharmaceutical Preparations
Bio Essence Corp
BIOE · Pharmaceutical Preparations
Bio Essence Corp is a California-based holding company whose operating history has centered on health supplements and OEM manufacturing/distribution services.
Last updated: 24/09/2026